Balanced news tone
News Sentiment
SNGX sentiment intelligence
Soligenix Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-0.3% over one week, -10.1% over four weeks, trend inactive, and below fair value.
Soligenix (SNGX) seeks reverse stock split, higher share authorization to protect Nasdaq listing
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Soligenix raises at‑market share capacity by $2.956M under sales agreement
Soligenix (SNGX) has increased the maximum amount of common stock available for sale under its at-market sales agreement by $2,956,000. This follows a prospectus supplement filed on May 28, 2026. The company had previously sold approximately $3,445,000 of common stock under the s
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 21:38
- Source
- TradingView
$Soligenix (SNGX.US)$ small win but consistent so far.
An investor, Delmas W, shared a brief post on the Moomoo community platform noting a "small win but consistent so far" with Soligenix (SNGX.US). The post was part of a discussion thread titled "Share Your Profit/Loss." The content itself is very minimal, serving more as a comment
- Tone
- Positive 60/100
- Event
- Earnings
- Published
- 28 May 2026 05:39
- Source
- Moomoo
Soligenix more than doubles as traders react to Ebola-outbreak vaccine-platform update
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 May 2026 07:00
- Source
- Quiver Quantitative
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Soligenix Announces Recent Updates and First Quarter 2026 Financial Results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 08 May 2026 11:30
- Source
- PR Newswire
Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Apr 2026 11:30
- Source
- PR Newswire
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Soligenix Announces Pricing of $7.5 Million Public Offering
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Sep 2025 07:00
- Source
- PR Newswire
Soligenix (SNGX) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Aug 2016 23:24
- Source
- MarketBeat